Dr. Pedro Lowenstein was a Keynote speaker at the Translational Research Cancer Centers Consortium (TRCCC) Annual Conference February 19-21, 2025. Dr. Lowenstein spoke on Reprogramming the immune microenvironment in glioblastoma: results from an immune-mediated gene therapy Phase I clinical trial.